Food and Drug Administration said on Monday it is seeking input on repurposing ‌approved drugs for potential new uses across a range ‌of diseases and conditions. Here are more details: • The regulator said it is seeking ​public input on identifying potential new uses for FDA approved drugs such as a new disease indication or a new patient population to speed up treatment availability by using existing knowledge about ‌the drugs.

The Food and Drug Administration on Friday issued a new guidance document that outlines the agency’s current approach for electronic nicotine delivery systems (ENDS) and nicotine pouch products that do not have premarket authorization.

The Food and Drug Administration’s flagship internal AI tool, Elsa, is being integrated with the data platform so that staff can accomplish work more easily.

President Donald Trump on Tuesday said US Food and Drug Administration (FDA) chief Marty Makary was leaving his post, a resignation that follows weeks of political tumult at the powerful agency. During his tenure atop the sprawling body responsible for overseeing vaccines,

Sanofi has asked the FDA to pull its type 1 diabetes drug out of Commissioner Marty Makary’s new speedy drug review program.

Market opportunities include gaining a comprehensive understanding of FDA procedures for US pharmaceutical submissions, critical for navigating the largest global market. This course provides deep insights into regulatory requirements and recent changes,

Acting Attorney General Todd Blanche signed an order Thursday to reclassify state-licensed medical marijuana as a less dangerous drug. The order shifts the designation of licensed medical marijuana from a high level of regulation to a much looser level.